¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ

An MRI-based imaging technique developed at the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.

Imaging techniques could replace the need for invasive tissue biopsies in helping rapidly determine whether cancer treatments are working effectively, according to researchers at the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ.

Nine ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ scientists are among the new Fellows announced today by the Royal Society. 

A new type of scan that involves magnetising molecules allows doctors to see in real-time which regions of a breast tumour are active, according to research at the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ and published in Proceedings of the National Academy of Sciences.

The next generation of imaging technology, newly installed at the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ, will give researchers an unprecedented view of the human body – in particular of the myriad connections within our brains and of tumours as they grow and respond to treatment – and could pave the way for development of treatments personalised for individual patients.

A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.

Cancer cells can now be viewed as never before, thanks to cutting-edge imaging tools being developed in ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ.

The ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Research Institute (CRI) is driving the development of new approaches for the early detection, prevention and treatment of cancer.